Lars Kaestner Selected Research

Lars Kaestner Research Topics

Disease

5	Hemolysis 07/2020 - 01/2013
4	Channelopathies 01/2023 - 01/2020
4	Neuroacanthocytosis 01/2022 - 01/2021
4	Cardiac Arrhythmias (Arrythmia) 11/2016 - 06/2012
3	hereditary Xerocytosis 01/2023 - 01/2019
3	Sickle Cell Anemia (Hemoglobin S Disease) 01/2021 - 05/2013
3	Anemia 01/2021 - 01/2017
2	Hypoxia (Hypoxemia) 01/2024 - 01/2022
2	Inflammation (Inflammations) 01/2023 - 02/2022
2	Hereditary Spherocytosis 01/2020 - 01/2019
2	Thalassemia 01/2019 - 05/2013
2	Heart Diseases (Heart Disease) 01/2016 - 07/2013
2	Hypertrophy 09/2015 - 07/2013
1	Congenital Hemolytic Anemia (Hemolytic Anemia, Congenital) 12/2023
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2023
1	Communicable Diseases (Infectious Diseases) 12/2022
1	COVID-19 12/2022
1	Infections 01/2021
1	Pain (Aches) 01/2020
1	Pyruvate Kinase Deficiency of Red Cells 01/2019
1	Glucosephosphate Dehydrogenase Deficiency 01/2019
1	Hemolytic Anemia 01/2019
1	Sinus Tachycardia 11/2016
1	Ischemia 11/2016
1	Thromboembolism 10/2016
1	Cardiomegaly (Heart Hypertrophy) 09/2015
1	Fibrosis (Cirrhosis) 09/2015
1	Genomic Instability 10/2012
1	Amyloid Plaque 01/2012
1	Alzheimer Disease (Alzheimer's Disease) 01/2012
1	Atrial Fibrillation 08/2010
1	Neoplasms (Cancer) 10/2008
1	Melanoma (Melanoma, Malignant) 10/2008
1	Testicular Neoplasms (Testicular Cancer) 10/2008
1	Vascular Remodeling 09/2006
1	Heart Failure 09/2006
1	Thrombosis (Thrombus) 12/2004
1	Psoriasis (Pustulosis Palmaris et Plantaris) 06/2003

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 01/2024 - 09/2006
3	Ion Channels (Ion Channel)IBA 01/2022 - 01/2020
3	CalciumIBA 01/2017 - 12/2004
2	Hemoglobins (Hemoglobin)IBA 01/2024 - 01/2019
2	Oxygen (Dioxygen)IBA 01/2024 - 01/2022
2	PhosphatidylserinesIBA 12/2023 - 01/2013
2	Biomarkers (Surrogate Marker)IBA 02/2022 - 01/2021
2	Dasatinib (BMS 354825)FDA Link 01/2022 - 12/2021
2	EnzymesIBA 01/2019 - 01/2016
2	Glutamic Acid (Glutamate)FDA Link 11/2016 - 10/2016
1	2,3-Diphosphoglycerate (2,3 Bisphosphoglycerate)IBA 01/2024
1	Blood Group Antigens (Blood Groups)IBA 01/2024
1	Fibrinogen (Factor I)FDA Link 01/2023
1	Blood Proteins (Serum Proteins)IBA 01/2023
1	SuspensionsIBA 12/2022
1	LithiumIBA 01/2022
1	Erythropoietin FDA Link 01/2022
1	nasIBA 01/2022
1	lysophosphatidic acidIBA 01/2021
1	SmokeIBA 01/2021
1	senicapocIBA 01/2021
1	voltage-dependent calcium channel (P-Q type)IBA 01/2021
1	Memantine (Namenda)FDA Link 07/2020
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 07/2020
1	SpectrinIBA 01/2019
1	Erythrocyte Anion Exchange Protein 1 (Band 3 Protein)IBA 01/2019
1	Glutathione Reductase (Glutathione-Disulfide Reductase)IBA 01/2019
1	Glutamate-Cysteine LigaseIBA 01/2019
1	AnkyrinsIBA 01/2019
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2018
1	SiliconIBA 01/2017
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 11/2016
1	AldosteroneIBA 10/2016
1	Hormones (Hormone)IBA 01/2016
1	CationsIBA 09/2015
1	Atrial Natriuretic Factor (ANF)IBA 09/2015
1	ReninIBA 09/2015
1	LipidsIBA 01/2015
1	Glucose (Dextrose)FDA LinkGeneric 01/2015
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2015
1	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 01/2015
1	NADPH Oxidases (NAD(P)H oxidase)IBA 07/2013
1	Reactive Oxygen Species (Oxygen Radicals)IBA 07/2013
1	PhosphofructokinasesIBA 05/2013
1	DNA (Deoxyribonucleic Acid)IBA 10/2012
1	Amyloid beta-PeptidesIBA 01/2012
1	GangliosidesIBA 01/2012
1	Amyloid (Amyloid Fibrils)IBA 01/2012
1	Monomeric GTP-Binding ProteinsIBA 08/2010
1	EpitopesIBA 10/2008
1	AntigensIBA 10/2008
1	Neoplasm Antigens (Tumor Antigens)IBA 10/2008
1	HLA-A*02:01 antigenIBA 10/2008
1	Dinoprostone (PGE2)FDA Link 12/2004
1	Prostaglandins EIBA 12/2004
1	zinc 1,4,8,11,15,18,22,25- octa- n- butoxyphthalocyanineIBA 06/2003

Therapy/Procedure

1	Therapeutics 12/2022
1	Hemodiafiltration 01/2022
1	Fluid Therapy (Oral Rehydration Therapy) 07/2020
1	Precision Medicine 01/2020